Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0000921895-26-001639

Options or other derivatives

  • Director acquired 22,195 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BVF PARTNERS L P/IL Director 2026-06-17 Grant or award · Option to Buy +22,195 22,195 I: show line 1 in the form
Loading xslF345X06/form407422mltx_06222026.xml…